Updated: April 19, 2026
About the program
Program type
Investment focus areas
Description
Hands-on early-stage life‑science investor and advisor offering deep, science-driven due diligence (PoC, MoA, animal models, KOL/clinician interviews) and access to pharma, corporate partnerships and stakeholder networks.
Location
Investment offer
Can lead rounds
No
Details
Avg Check: $500K - $1M ·